Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases
Clinical trial NCT03498612 · TERMINATED
Trial details
- NCT number
- NCT03498612
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2021-06-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.